Congenital myasthenic syndrome 13

Any congenital myasthenic syndromes with glycosylation defect in which the cause of the disease is a mutation in the DPAGT1 gene.

Also known as: CMS13, CMSTA2, DPAGT1 congenital myasthenic syndromes with glycosylation defect, congenital myasthenic syndrome type 13, congenital myasthenic syndromes with glycosylation defect caused by mutation in DPAGT1, myasthenic syndrome, congenital, 13, with tubular aggregates, myasthenic syndrome, congenital, type 13, myasthenic syndrome, congenital, 13

1 clinical trial for this condition and its sub-types.